BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:cizutamig readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of cizutamig\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07158996-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:cizutamig: Phase 1 readout est. (NCT07158996)
DESCRIPTION:cizutamig\, phase 1.\nStudy: A Study of Cizutamig in Systemic S
 clerosis\nEstimated primary completion: 1 December 2026. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/cizutamig#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT07158996
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06946199-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:cizutamig: Phase 1 readout est. (NCT06946199)
DESCRIPTION:cizutamig\, phase 1.\nStudy: An Open-label Study of Cizutamig i
 n Refractory Seropositive Rheumatoid Arthritis\nEstimated primary completi
 on: June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/cizuta
 mig#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 06946199
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07353450-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:cizutamig: Phase 1 readout est. (NCT07353450)
DESCRIPTION:cizutamig\, phase 1.\nStudy: A Study of Cizutamig for Patients 
 With Ulcerative Colitis\nEstimated primary completion: December 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/cizutamig#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07353450
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07215663-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:cizutamig: Phase 1 readout est. (NCT07215663)
DESCRIPTION:cizutamig\, phase 1\, Systemic Lupus Erythematosus.\nStudy: Cli
 nical Study of Cizutamig in Systemic Lupus Erythematosus\nEstimated primar
 y completion: December 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/cizutamig#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT07215663
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07215650-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:cizutamig: Phase 1 readout est. (NCT07215650)
DESCRIPTION:cizutamig\, phase 1.\nStudy: Clinical Study of Cizutamig in Gen
 eralized Myasthenia Gravis (gMG)\nEstimated primary completion: December 2
 027. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/cizutamig#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07215650
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07597200-1345@assetmemo.bio
DTSTAMP:20261121T005636Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:cizutamig: Phase 1 readout est. (NCT07597200)
DESCRIPTION:cizutamig\, phase 1.\nStudy: A Clinical Study of Cizutamig in T
 hyroid Eye Disease\nEstimated primary completion: 31 May 2028. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/cizutamig#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07597200
URL:https://assetmemo.bio/drug/cizutamig#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
